Abu Dhabi’s (DoH) Policy on Assisted Reproductive Services

By Danélia Botes

February 17, 2023

Understanding THIQA’s Policy on Assisted Reproductive Services

THIQA’s policy outlines the eligibility criteria, benefits, and reimbursement packages for Assisted Reproductive Techniques (ART) in Abu Dhabi. It is not a clinical management guideline, but rather a framework to ensure eligible patients in need of ART treatments receive coverage based on evidence-based medical criteria.

Determining Medical Necessity in Assisted Reproductive Treatments

THIQA covers Assisted Reproductive treatments deemed medically necessary. This could be due to a couple trying for pregnancy for at least a year, or one or both individuals diagnosed with infertility problems. Infertility can also be diagnosed prior to one year if there are features or findings indicative of subfertility, such as oligo or amenorrhea, history of pelvic infection, or abnormality in semen parameters.

Eligibility and Covered Services

The preferred age range for women seeking fertility is between 18-47 years. Exceptions apply for fertility preservation in female patients diagnosed with cancer. The Body Mass Index (BMI) eligibility range is from 19-40. Covered services include treatment, oocyte and embryo cryopreservation, transfer of embryos, medications, in vitro fertilisation (IVF), and genetic investigations.

The Future of Assisted Reproductive Services

The policy is a testament to the commitment of THIQA and other life sciences consulting firms to provide value-based healthcare. With advancements in artificial intelligence consulting services, we can expect more personalised and effective treatments in the future.

 

Reference url

Recent Posts

AI Drug Safety Surveillance
           

Created and Validated by FDA: AI Drug Safety Surveillance Tool

🚀 Discover how the AI-driven LabelComp tool is transforming drug safety surveillance! By automating the identification of adverse events in drug labelling, LabelComp enhances accuracy and efficiency, supporting regulatory decision-making and public health. 🌐💊
#SyenzaNews #AIinHealthcare #DrugSafety #PharmaInnovation #RegulatoryScience

School-based health centres
                      

The Role of School-Based Health Centres in Advancing Health Equity

🌟 School-based health centres (SBHCs) are improving healthcare for underserved youth across the US! These centres provide vital services, from preventive care to chronic disease management, right where students need them most – in schools. 📚🏥

SBHCs improve academic performance, reduce absenteeism, and enhance overall student well-being. Let’s support these essential centres and ensure every child has access to quality healthcare. 🌟

#SyenzaNews #SBHC #ChronicDiseaseManagement #HealthEquity #PreventiveCare

ABA guidelines for Autism
                

Enhancing Care in Abu Dhabi: The New ABA Guidelines for Autism

🌟 Exciting developments in Abu Dhabi! The Department of Health has introduced new ABA guidelines for Autism Spectrum Disorder, aiming to improve care for People of Determination. This initiative focuses on standardising care, enhancing accessibility, and fostering collaboration between healthcare and education professionals.
Learn more about how these guidelines can make a difference in the lives of individuals with ASD.
#SyenzaNews #HealthcareInnovation #AutismCare #InclusiveHealth #ABAGuidelines #AbuDhabiHealth

When you collaborate with VSH Foundation, it's like unlocking a new dimension in healthcare innovation.

Our research synergizes with your vision, combining expertise in health economics, policy analysis, advanced analytics, and AI applications in healthcare. You’ll witness the fusion of cutting-edge methodologies and real- world impact, as we work together to transform healthcare systems and improve patient outcomes globally.

CORRESPONDENCE ADDRESS

PO Box 8547, #95478, Boston, MA 02114, USA

© 2024 Value Science Health Foundation. All rights reserved.
Made with by Frogiez